What is Alumis Inc.'s change in deferred revenue?

Alumis Inc. (ALMS) reported change in deferred revenue of $2.26M in Q1 2026.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Alumis Inc. ALMS Change in Deferred Revenue

Change in Deferred Revenue at other companies

ImmunomeIMNM

$0+100%

Aurinia PharmaceuticalsAUPH

$1.08M-75.1%

Dianthus TherapeuticsDNTH

$849K+1,589%

Protagonist TherapeuticsPTGX

-$3.27M+40.5%

Kymera TherapeuticsKYMR

-$34.37M-1,536%

Adaptive BiotechnologiesADPT

$4M+220%

Other financials

Income statement

See full

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Balance sheet

See full

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Cash flow

See full

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Valuation

See full

Market cap$3.17B+739%

Profitability

See full

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Returns & leverage

See full

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alumis Inc.'s change in deferred revenue?: Alumis Inc. (ALMS) reported change in deferred revenue of $2.26M in Q1 2026.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.